Lexeo Therapeutics (LXEO) Institutional Ownership $7.93 +0.03 (+0.38%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lexeo Therapeutics (NASDAQ:LXEO)CurrentInstitutional OwnershipPercentage60.67%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$98.70MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$5.98M Get LXEO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LXEO Institutional Buying and Selling by Quarter Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Lexeo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/24/2024 Novo Holdings A S1,122,581$10.15M0.5%-22.6%3.407% 10/23/2024 Values First Advisors Inc.7,446$67K0.0%N/A0.023% 8/20/2024 Novo Holdings A S1,450,500$23.27M1.2%-11.5%4.403% 8/1/2024Rhumbline Advisers13,357$214K0.0%+37.3%0.041% 7/26/2024Bank of New York Mellon Corp31,806$510K0.0%+12.3%0.097% 5/17/2024RA Capital Management L.P.660,938$10.36M0.1%N/A2.006% 5/17/2024Artal Group S.A.801,716$12.57M0.3%+32.9%2.434% 5/16/2024Janus Henderson Group PLC2,540,785$39.80M0.0%+9.0%7.713% 5/14/2024American International Group Inc.5,053$79K0.0%N/A0.015% 5/10/2024Vanguard Group Inc.481,755$7.55M0.0%+15.8%1.462% 5/1/2024BNP Paribas Financial Markets4,781$75K0.0%N/A0.015% 4/29/2024Cornell University126,258$1.98M30.0%N/A0.383% 2/20/2024Eventide Asset Management LLC3,002,831$40.30M0.7%N/A11.268% 2/15/2024Omega Fund Management LLC2,157,623$28.96M23.5%N/A8.096% 2/15/2024Blackstone Inc.696,110$9.34M0.0%N/A2.612% (Data available from 1/1/2016 forward) LXEO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LXEO shares? During the previous two years, 14 institutional investors and hedge funds held shares of Lexeo Therapeutics. The most heavily invested institutionals were Eventide Asset Management LLC ($40.30M), Janus Henderson Group PLC ($39.80M), Omega Fund Management LLC ($28.96M), Artal Group S.A. ($12.57M), RA Capital Management L.P. ($10.36M), Novo Holdings A S ($10.15M), and Blackstone Inc. ($9.34M).Learn more on LXEO's institutional investors. What percentage of Lexeo Therapeutics stock is owned by institutional investors? 60.67% of Lexeo Therapeutics stock is owned by institutional investors. Learn more on LXEO's institutional investor holdings. Which institutional investors have been buying Lexeo Therapeutics stock? Of the 13 institutional investors that purchased Lexeo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.00M), Omega Fund Management LLC ($2.16M), Blackstone Inc. ($696.11K), RA Capital Management L.P. ($660.94K), Janus Henderson Group PLC ($210.05K), Artal Group S.A. ($198.28K), and Cornell University ($126.26K). How much institutional buying is happening at Lexeo Therapeutics? Institutional investors have bought a total of 7,142,051 shares in the last 24 months. This purchase volume represents approximately $98.70M in transactions. Which Lexeo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Lexeo Therapeutics stock in the last 24 months: Novo Holdings A S ($515.72K). How much institutional selling is happening at Lexeo Therapeutics? Institutional investors have sold a total of 515,717 shares in the last 24 months. This volume of shares sold represents approximately $5.98M in transactions. Related Companies Phathom Pharmaceuticals Institutional Ownership Evolus Institutional Ownership IGM Biosciences Institutional Ownership Applied Therapeutics Institutional Ownership Bicycle Therapeutics Institutional Ownership ArriVent BioPharma Institutional Ownership Prothena Institutional Ownership Arcutis Biotherapeutics Institutional Ownership Zymeworks Institutional Ownership Mesoblast Institutional Ownership This page (NASDAQ:LXEO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
